RecruitingNot ApplicableNCT05112328

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial

Sponsor

Seoul National University Hospital

Enrollment

170 participants

Start Date

Jul 7, 2021

Study Type

INTERVENTIONAL

Conditions

enteral feeding Exocrine Pancreatic Insufficiency Critically Ill

Summary

Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Exocrine Pancreatic Enzyme and a drug called Placebo for people with critically ill, exocrine pancreatic insufficiency, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.